-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Revenues history and growth rate from 2014 to 2022.
- Regenerx Biopharmaceuticals Inc Revenues for the quarter ending March 31, 2023 was $19.2K, a 0.01% decline year-over-year.
- Regenerx Biopharmaceuticals Inc Revenues for the twelve months ending March 31, 2023 was $76.8K, a 0% decline year-over-year.
- Regenerx Biopharmaceuticals Inc annual Revenues for 2022 was $76.8K, unchanged from 2021.
- Regenerx Biopharmaceuticals Inc annual Revenues for 2021 was $76.8K, unchanged from 2020.
- Regenerx Biopharmaceuticals Inc annual Revenues for 2020 was $76.8K, a 0% decline from 2019.